Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells

Recent studies have established that interleukin (IL)-10 induces growth and most notably differentiation of normal human B lymphocytes. We studied here the effects of IL-10 on the proliferation and survival of B-chronic lymphocytic leukemia (B-CLL) cells. IL-10 was found to inhibit 54-96% of the spontaneous tritiated thymidine incorporation observed in 3 of 12 B-CLL samples. Furthermore, IL-10 decreased the viable cell recovery of all five B-CLL samples tested, irrespective of whether cells were spontaneously synthesizing DNA or not. After 1 wk, B- CLL populations cultured with IL-10 were lost while those cultured without IL-10 survived. Flow cytometric analysis, DNA gel electrophoresis, and Giemsa staining all revealed that IL-10 induced B- CLL cells to die from apoptosis. This IL-10-mediated apoptosis was dose dependent and specific as it could be inhibited by a neutralizing anti- IL-10 antibody. B-CLL cells undergoing apoptosis in response to IL-10 showed decreased Bcl-2 protein levels. Addition of IL-2, IL-4, interferon gamma, and anti-CD40 monoclonal antibody prevented the IL-10- mediated apoptosis of B-CLL cells. None of the malignant B cell populations obtained from eight non-Hodgkin's lymphomas and three hairy cell leukemias underwent apoptosis after IL-10 treatment, thus suggesting that the apoptotic effect of IL-10 is specific for B-CLL cells. Thus, IL-10 inhibits the DNA synthesis and most notably the survival of B-CLL cells, findings that call for considering IL-10 in the immunotherapy of chemoresistant B-CLL.

• Publication year

  1994

• Venue

  Journal of Experimental Medicine

• Publication date

  1994-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1084/JEM.179.1.91PMID 8270886PMCID 2191337
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10

  1993cited by this paper
• Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus

  1993cited by this paper
• Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha.

  1993cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993cited by this paper
• Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes

  1993cited by this paper
• Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia

  1993cited by this paper
• bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

  1993cited by this paper
• Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.

  1992cited by this paper
• Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A

  1992cited by this paper
• Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression

  1992influential reference
• Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene.

  1992cited by this paper
• In vivo production of interleukin‐10 by malignant cells in AIDS lymphomas

  1992cited by this paper
• Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.

  1992cited by this paper
• Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

  1992cited by this paper
• Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry.

  1992cited by this paper
• Human B lymphocytes: phenotype, proliferation, and differentiation.

  1992cited by this paper
• Cooperative interaction between c-myc and bcl-2 proto-oncogenes

  1992cited by this paper
• B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL.

  1991cited by this paper
• Long-term human B cell lines dependent on interleukin-4 and antibody to CD40.

  1991cited by this paper
• Differential inhibition of interleukin 2‐ and interleukin 4‐mediated human B cell proliferation by ionomycin: A possible regulatory role for apoptosis

  1991cited by this paper
• Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells.

  1991cited by this paper
• Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.

  1991cited by this paper
• Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis

  1991cited by this paper
• Molecular and cellular origins of B lymphocyte diversity.

  1991cited by this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cited by this paper
• Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

  1990cited by this paper
• Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

  1990cited by this paper
• Spontaneous programmed death (apoptosis) of B‐chronic lymphocytic leukaemia cells following their culture in vitro

  1989cited by this paper
• Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways.

  1989cited by this paper
• Mechanism of antigen-driven selection in germinal centres

  1989cited by this paper
• Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

  1989cited by this paper
• Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells

  1988cited by this paper
• Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

  1988cited by this paper
• Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor.

  1987cited by this paper
• Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro.

  1986cited by this paper
• Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2

  1986cited by this paper
• Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

  1984cited by this paper
• An endotoxin-induced serum factor that causes necrosis of tumors.

  1975cited by this paper

• A dual-role for IL-10: From leukemogenesis to the tumor progression in acute lymphoblastic leukemia.

  2023cites this paper
• Interleukin-10-1082A>G (rs1800896) Single Nucleotide Polymorphism is Not a Risk Factor of Chronic Lymphocytic Leukemia in Sudanese Population

  2022cites this paper
• IL-10 in cancer: an essential thermostatic regulator between homeostatic immunity and inflammation - a comprehensive review.

  2022cites this paper
• Ex vivo culture of malignant primary B cells

  2022cites this paper
• IL-10 Rescues CLL Survival through Repolarization of Inflammatory Nurse-like Cells

  2021cites this paper
• Clinical significance of interleukin-10 concentration in the cerebrospinal fluid of patients with primary central nervous system lymphoma

  2020cites this paper
• Chronic Lymphocytic Leukemia

  2018cites this paper
• Chronic Lymphocytic Leukemia–Derived IL-10 Suppresses Antitumor Immunity

  2018cites this paper
• The Use of Anti-CD40 mAb in Cancer.

  2017cites this paper
• Cancer Vaccines

  2017cites this paper
• SUPPRESSION OF ANTI-TUMOR IMMUNITY IN CHRONIC LYMPHOCYTIC LEUKEMIA VIA INTERLEUKIN-10 PRODUCTION

  2016influential citation
• Estimation of zeta-chain-associated protein 70, interleukin-6 and interleukin-10 levels in sera of Iraqi newly diagnosed chronic lymphocytic leukemia

  2016cites this paper
• Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia

  2016cites this paper
• Derived IFN- - Express CD38 in Response to Th1 Cell Chronic Lymphocytic Leukemia Cells

  2015cites this paper
• Chronic Lymphocytic Leukemia Cells Express CD38 in Response to Th1 Cell–Derived IFN-γ by a T-bet–Dependent Mechanism

  2015cites this paper
• Mediate Tumor Rejection Cutting Edge: IL-10-Producing CD4+ T Cells

  2013cites this paper
• HCD122, on human chronic lymphocytic leukemia cells The antileukemia activity of a human anti-CD40 antagonist antibody,

  2013cites this paper
• CD180/RP105 Toll-like Receptor (TLR) mediated signalling in Chronic Lymphocytic Leukaemia

  2013influential citation
• Understanding the immunodeficiency in chronic lymphocytic leukemia: potential clinical implications.

  2013cites this paper
• Serum Tumor Necrosis Factor-α and Interleukin-10 Levels as Markers to Predict Outcome of Patients with Chronic Lymphocytic Leukemia in Different Risk Groups Defined by the IGHV Mutation Status

  2012cites this paper
• CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma

  2011cites this paper
• chronic lymphocytic leukemia B cells from in vitro apoptosis Interleukin-13 inhibits interleukin-2-induced proliferation and protects

  2011cites this paper
• leukemia cells by prolonging survival in an autocrine fashion Interleukin-8 induces the accumulation of B-cell chronic lymphocytic

  2010cites this paper
• In vitro induction of apoptotic cell death in chronic lymphocytic leukemia by two natural products: preliminary study.

  2010cites this paper
• Current Concepts: Mouse Models of Sjögren's Syndrome

  2010cites this paper
• T-cell function in chronic lymphocytic leukaemia.

  2010cites this paper
• Perfil de citocinas inflamatórias em indivíduos submetidos a procedimentos cirúrgicos utilizando propofol ou isoflurano

  2010cites this paper
• CLL: a paradigm of tumor-associated immune dysfunction

  2008cites this paper
• Potential role of IL-10-treated dendritic cells in the control of the immune response to allergens

  2008cites this paper
• Role of STAT3 in glucocorticoid-induced expression of the human IL-10 gene.

  2008cites this paper
• The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells.

  2008cites this paper
• Markers of apoptosis and proliferation related gene products as predictors of treatment outcome in childhood acute lymphoblastic leukemia

  2007cites this paper
• Studies on Redox-proteins and Cytokines in inflammation and Cancer

  2007cites this paper
• Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: Correlation with disease stage and prognosis

  2007cites this paper
• Inflammation and Cancer

  2007cites this paper
• Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome.

  2007cites this paper
• CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.

  2007cites this paper
• Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.

  2006cites this paper
• Emerging drugs for chronic lymphocytic leukaemia

  2006cites this paper
• Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules

  2006cites this paper
• Cancer as a chronic inflammatory disease: role of immunotherapy

  2004cites this paper
• Cytokines and Soluble Molecules in CLL

  2004cites this paper
• Cytokine therapy in rheumatoid arthritis

  2004cites this paper
• The role of CD40-CD154 interaction in cell immunoregulation.

  2004cites this paper
• Interleukin-10 and related cytokines and receptors.

  2004cites this paper
• Pathogenesis of Impaired Cellular Immune Function in CLL

  2004cites this paper
• RNA interference of IL-10 in leukemic B-1 cells.

  2004cites this paper
• Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma

  2004cites this paper
• The Role of CD40-CD154 Interaction in Cell Immunoregulation

  2004cites this paper
• Prospects for CD40-directed experimental therapy of human cancer

  2003cites this paper
• B-1 and B-2 B cell responses to lipopolysaccharide: Putative roles in the pathogenesis of periodontitis.

  2003cites this paper
• Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells.

  2003cites this paper
• Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.

  2003cites this paper
• Production of intracellular IL‐2, TNF‐α, and IFN‐γ by T cells in B‐CLL

  2003cites this paper
• IL‐10 expression profiling in human monocytes

  2002cites this paper
• Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells.

  2002cites this paper
• In vitro production of anti‐RBC antibodies and cytokines in chronic lymphocytic leukemia

  2002cites this paper
• Factor(s) released from irradiated B-CLL cells induce apoptosis in leukemic lymphocytes.

  2002cites this paper
• Cutting Edge: IL-10-Producing CD4+ T Cells Mediate Tumor Rejection1

  2002cites this paper
• Carcinogenicity testing of IL-10: principles and practicalities

  2002cites this paper
• Cytoprotective antioxidant activity of serum albumin and autocrine catalase in chronic lymphocytic leukaemia

  2002cites this paper
• γ-Linolenic Acid Induces Apoptosis in B-Chronic Lymphocytic Leukaemia Cells in Vitro

  2001cites this paper
• Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia

  2001cites this paper
• Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis.

  2001cites this paper
• Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis

  2001cites this paper
• Over-Expression of the Functional Interleukin-11α Receptor in the Development of B-Cell Chronic Lymphocytic Leukemia

  2001cites this paper
• Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome.

  2001cites this paper
• Expression and Production of Interleukin 4 in B-Cell Chronic Lymphocytic Leukaemia

  2001cites this paper
• Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.

  2001cites this paper
• Cell cycle effects of IL-10 on malignant B-1 cells

  2001cites this paper
• Tumor Rejection T Cells + Cutting Edge : IL-10-Producing CD 4

  2001cites this paper
• The levels of TNF alpha, IL4 and IL10 production by T-cells in B-cell chronic lymphocytic leukaemia (B-CLL).

  2001cites this paper
• Dendritic cells in patients with non‐progressive B‐chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern

  2001cites this paper
• Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B‐CLL patients: impact on clonal B‐cell apoptosis

  2001cites this paper
• In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity

  2000cites this paper
• Biology of chronic lymphocytic leukemia.

  2000cites this paper
• cells Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia

  2000cites this paper
• The cAMP Signaling Pathway as a Therapeutic Target in Lymphoid Malignancies

  2000cites this paper
• Accessory cells, cytokine loops and cell-to-cell interactions in chronic lymphocytic leukemia.

  2000cites this paper
• Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemia.

  2000cites this paper
• Role of β2 integrins in the prevention of apoptosis induction in chronic lymphocytic leukemia B cells

  2000cites this paper
• Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells.

  2000cites this paper
• Interleukin 10 modulation of tumour necrosis factor receptors requires tyrosine kinases but not the PI 3-kinase/p70 S6 kinase pathway.

  2000cites this paper
• In vitro evaluation of B-CLL cells apoptotic responses to irradiation.

  1999cites this paper
• Transgenic for IL-10 Resembling Sjögren's Syndrome in Mice Fas Ligand-Mediated Exocrinopathy

  1999cites this paper
• Serum beta-2-microglobulin, TNF-alpha and interleukins in myeloproliferative disorders.

  1999cites this paper
• Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.

  1999cites this paper
• Serum beta‐2‐microglobulin, TNF‐α and interleukins in myeloproliferative disorders

  1999cites this paper
• Cytokine expression in B-CLL in relation to disease progression andin vitro activation

  1999cites this paper
• Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia.

  1999cites this paper
• Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production

  1999cites this paper
• Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by Bcl-2

  1999cites this paper
• What is the real role of CD40 in cancer immunotherapy?

  1999cites this paper
• Interleukin 10 produced by macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apoptosis by reduction of TNF-alpha activity.

  1999cites this paper
• IFN-alpha Stimulates Proliferation and Cytokine Secretion of CD40-Stimulated B Cell Chronic Lymphocytic Leukemia Cells In Vitro

  1999cites this paper
• Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.

  1999cites this paper
• Apoptosis in human autoimmune diseases.

  1999cites this paper
• Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10.

  1999cites this paper
• Apoptosis of human T-cells: induction by glucocorticoids or surface receptor ligation in vitro and ex vivo.

  1999cites this paper
• B-cell chronic lymphocytic leukemia: a bird of a different feather.

  1999cites this paper